REHOVOT, Israel, March 28, 2007 (PRIME NEWSWIRE) (PRIMEZONE) -- Rosetta Genomics, Ltd. (Nasdaq:ROSG) announced today that Dr. Dalia Cohen, the company’s Global Head of Research and Development, will be presenting at Cambridge Healthtech Institute’s microRNA in Human Disease and Development conference taking place March 29 - 30, 2007 in Boston, MA.
